Jae Cheon Ryu
Neuroscience · The Ohio State University
Publications
11
Citations
505
Est. group size
—
Recurring co-author estimate
Active years
14
Publishing since 2012
Jae Cheon Ryu's recent work focuses on gene therapy approaches for GBA1-related diseases, including Gaucher Disease and GBA-associated Parkinson's Disease. The research uses AAV (adeno-associated virus) vectors, a common tool for delivering therapeutic genes to cells, with related interests in nerve regeneration, cell signaling, and stress responses within cells (particularly involving structures like lysosomes and the endoplasmic reticulum).
Publication output has been low and irregular over the past decade, with several years showing no recorded output, though there is recent activity in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- AAV gene therapy for GBA-PD and Gaucher Disease
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- AAV gene therapy for GBA1-related diseases
Molecular Therapy · 2025
- Journal of Neuroscience×2
- ACS Medicinal Chemistry Letters×2
- Journal of Clinical Investigation×1
- Molecular Therapy×1
- Diabetes×1
- Giles W. Plant
Neuroscience · The Ohio State University
- Andrea Tedeschi
Neuroscience · The Ohio State University
- Sung Ok Yoon
Neuroscience · The Ohio State University
- Angela R. Filous
Neuroscience · The Ohio State University
- Ilaria Palmisano
Neuroscience · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile